美托洛尔及厄贝沙坦氢氯噻嗪在老年重症心力衰竭急诊内科治疗中的应用  

Metoprolol and irbesartan hydrochlorothiazide emergency medical treatment in elderly patients with severe heart failure

作　　者：侯健民[1] 黄国孟[1] 

机构地区：[1]广东省广州市第一人民医院急诊科,广东广州510000

出　　处：《吉林医学》2012年第27期5874-5875,共2页Jilin Medical Journal

摘　　要：目的:探讨急诊内科治疗老年重症心力衰竭患者的临床疗效。方法:选取老年重症心力衰竭患者150例,将其随机分为观察组和对照组各75例,对照组采用常规治疗,观察组在常规治疗基础上加用美托洛尔及厄贝沙坦氢氯噻嗪联合治疗,两组均治疗3个月,治疗后比较两组的临床治疗效果。结果:治疗后观察组总有效率为97.33%,明显高于对照组的88.00%,两组差异有统计学意义(P<0.05)。结论:美托洛尔联合厄贝沙坦氢氯噻嗪治疗老年重症心力衰竭,疗效显著,患者心功能明显改善,值得临床推广应用。Objective To explore the clinical efficacy of emergency medical treatment on elderly patients with severe heart failure.Methods 150 cases of elderly patients with severe heart failure were sleeted,and were randomly divided into observation group and control group 75 cases in each,the control group were given conventional therapy, the treatment group were treated with metoprolol and irbesartan hydrochlorothiazide thiazide on the basic of conventional therapy, two groups were treated for 3 months,clinical efficacy were compared after treatment.Results After treatment the total effective rate was 97.33% in observation group,which was significantly higher than 88.00% of the control group,the difference was statistically significant（P 〈 0.05）.Conclusion The treatment of metoprolol and irbesartan hydrochlorothiazide thiazide on elderly patients with severe heart failure is effective,can significantly improve the cardiac function,is worthy of clinical application.

关 键 词：老年重症心力衰竭 美托洛尔 厄贝沙坦氢氯噻嗪 

分 类 号：R541.6[医药卫生—心血管疾病]